June 2015
Volume 56, Issue 7
ARVO Annual Meeting Abstract  |   June 2015
Minocycline abrogates glycated albumin induced MCP-1 and IL-8 cytokine release from ARPE-19 cells
Author Affiliations & Notes
  • Joanna DaCosta
    Cranfield University, Bedfordshire, United Kingdom
  • Footnotes
    Commercial Relationships Joanna DaCosta, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 840. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Joanna DaCosta; Minocycline abrogates glycated albumin induced MCP-1 and IL-8 cytokine release from ARPE-19 cells. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):840.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Reduced choroidal blood flow may create hypoxia in the retina, triggering formation of new vessels through the activation of vascular endothelial growth factor. This may initiate neovascular age-related macular degeneration.Glycated human serum albumin (GHSA) has been shown to stimulate RPE cells to produce IL-8 and MCP-1. Early glycated albumin may have a direct impact on cell function during ageing. Minocycline is a semisynthetic derivative of tetracycline with a longer half life and improved penetration through the blood brain barrier. Apart from antimicrobial effects it also has potent anti-inflammatory and immunomodulatory effects. It<br /> was postulated that minocyline may suppress the induced expresion of inflammatory cytokines from retinal pigment epithelial cells in culture.

Methods: Research was conducted on human ARPE-19 cells in culture. Cells were exposed to hypoxia and GHSA. Minocycline was investigated for the effect on cell growth and cell viability. Cell counts were obtained with a Scepter cell counter (Millipore). Cell viability and apoptosis rates were investigated with annexin V and propidium iodide staining by flow cytometry. The effects of hypoxia and different concentrations of GHSA, IL-1â, TNF-á on cell viability and with treatment with minocycline were investigated. ELISA for IL-8 and MCP-1 was conducted with appropriate negative and positive controls. Standards and samples were analysed in duplicate. Intraplate and interplate reproducibility tests were performed.

Results: Cell viability decreased at minocycline doses above 5mM. Hypoxia increased the proportion of non viable cells and cells undergoing apoptosis and minocycline treated cells had a lower proportion in the early stage of apoptosis. ELISA results demonstrated that hypoxia and GHSA treated cells showed a significantly increased MCP-1 production. Minocycline significantly reduced MCP-1 production in normoxic conditions (p< 0.01)and also decreased MCP-1 production in hypoxia (p<0.05). For IL-8, minocycline significantly reduced production in normoxia (p<0.01) but not statistically significantly under hypoxia.

Conclusions: The results suggest that minocycline abrogates the production of inflammatory cytokines IL-8 and MCP-1 in cell culture and minocycline may have a therapeutic role in the treatment of inflammatory changes in age related macular degeneration.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.